Form 4: Personalis CFO/COO Granted Significant Equity Awards

Personalis, Inc.'s CFO and COO, Aaron Tachibana, was granted 34,375 restricted stock units and options to purchase 206,250 shares of common stock.

Summary

• Aaron Tachibana, the Chief Financial Officer and Chief Operating Officer of Personalis, Inc. (PSNL), acquired new equity awards.
• The awards include 34,375 shares of common stock in the form of Restricted Stock Units (RSUs).
• These RSUs were acquired at a price of $0 and will vest in 6 equal semi-annual installments, with the first installment vesting on September 15, 2026.
• Additionally, 206,250 stock options were granted, allowing the right to buy common stock at an exercise price of $6.72 per share.
• The stock options will vest in 36 equal monthly installments, with the first installment vesting on April 15, 2026, and have an expiration date of March 15, 2036.
• Following these transactions, Aaron Tachibana beneficially owns 198,833 shares of common stock and 206,250 derivative securities (stock options).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, primarily due to the enhanced alignment of executive incentives with shareholder interests, which is a standard and healthy corporate governance practice.

Positives

• The equity grants align the interests of a key executive, Aaron Tachibana, with those of shareholders, incentivizing long-term company performance.
• The vesting schedules for both RSUs and stock options promote executive retention over several years.

Negatives

• The issuance of new equity awards, particularly stock options, can lead to potential future dilution for existing shareholders if exercised.

Risks

• The value of the granted RSUs and stock options is contingent on the future performance of Personalis, Inc.'s stock price.
• The awards are subject to vesting schedules, meaning the executive must remain employed by the company for the awards to fully materialize.

Future Outlook

The equity grants, with their multi-year vesting schedules, indicate an expectation of continued executive leadership and a long-term commitment to the company's performance by Aaron Tachibana. The value realized from these awards is directly tied to the future success and stock price appreciation of Personalis, Inc.

Industry Context

StockSavvy.ai notes that equity compensation, including RSUs and stock options, is a standard practice across the biotechnology and technology sectors. These grants are commonly used to attract, retain, and incentivize key executives by aligning their financial interests with the long-term performance of the company's stock.

Comparison to Industry Standards

• Equity compensation packages for senior executives, comprising a mix of restricted stock units and stock options, are a common and widely accepted practice in the U.S. public markets, particularly within growth-oriented sectors like biotechnology.
• While specific grant sizes vary based on company size, executive role, and performance, the structure of these awards (vesting over several years) is consistent with industry benchmarks aimed at long-term retention and performance alignment.
• No specific comparable companies or projects are mentioned in the filing to allow for a direct quantitative comparison of the grant size.

Stakeholder Impact

• Shareholders: Potential for minor future dilution upon exercise of options, but also benefit from increased executive alignment and retention.
• Employees: The compensation structure for a key executive may set a precedent or reflect the company's overall approach to incentivizing its leadership team.

Next Steps

• The RSUs will begin vesting in semi-annual installments starting September 15, 2026.
• The stock options will begin vesting in monthly installments starting April 15, 2026.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a key executive, which is a standard compensation practice. While it indicates continued executive commitment, it does not present new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation based solely on this disclosure. Investors should continue to hold and monitor broader company performance and market conditions.

Keywords

Personalis, PSNL, Aaron Tachibana, CFO, COO, Restricted Stock Units, RSUs, Stock Options, Equity Grant, Insider Transaction, Form 4, Executive Compensation